Courtney Cape, OD
Optometrist · Dyersburg, TNNPI 1396398855
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (45.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Sun Pharmaceutical Industries Inc. at 56.3% of the total. Reporting peaked in 2023 at $28,704 and has fallen 66.1% since, to $9,744 in 2025. Among optometrist clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 355 payments — averaging $144.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$29K
- AbbVie$15K
- Oyster Point Pharma, Inc.$1K
- Bausch & Lomb Americas Inc.$954
- Glaukos Corporation$860
- Eyevance Pharmaceuticals LLC$858
- plus $4K from 22 others
What the payments were for
- Consulting fees$2,4505%
- Speaking & faculty fees$23,15045%
- Travel & lodging$11,96023%
- Food & beverage$13,63327%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 109 | $28,807 |
| AbbVie(2 entities) | 68 | $14,669 |
| Oyster Point Pharma, Inc. | 32 | $1,319 |
| Bausch & Lomb Americas Inc. | 30 | $954 |
| Glaukos Corporation | 7 | $860 |
| Eyevance Pharmaceuticals LLC | 11 | $858 |
| Alcon | 18 | $705 |
| Harrow Eye, LLC | 18 | $618 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 7 | $406 |
| Johnson & Johnson Vision Care, Inc. | 6 | $370 |
| Tarsus Pharmaceuticals, Inc. | 10 | $260 |
| Kala Pharmaceuticals, Inc. | 6 | $245 |
| Biotissue Holdings Inc. | 6 | $239 |
| Aerie Pharmaceuticals, Inc. | 2 | $146 |
| Sight Sciences, Inc. | 3 | $127 |
| Dompe US, Inc. | 3 | $119 |
| Carl Zeiss Meditec, Inc. | 1 | $87 |
| Quidel Corporation | 3 | $85 |
| Amgen(2 entities) | 3 | $79 |
| Thea Pharma Inc. | 2 | $64 |
| Novartis | 2 | $38 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $36 |
| Rxsight Inc | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Apellis Pharmaceuticals, Inc. | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
| Mallinckrodt Enterprises LLC | 1 | $16 |
| NEW World Medical,inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CEQUA$27,037
- VUITY$12,021
- LUMIGAN$1,050
- ALPHAGAN P$700
- COMBIGAN$700
- TYRVAYA$694
- Zerviate$396
- RESTASIS$373
- KXL System$357
- Photrexa$357
- Rhopressa$246
- Rocklatan$246
- VYZULTA$239
- Acuvue$237
- INFUSE$225
- Flarex$148
- Hydrus Microstent$145
- Tobradex ST$125
- EYSUVIS$121
- SIMBRINZA$121
How this compares
$51,201 in reported general payments places this provider in the 95th percentile of 1,122 optometrist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 148 | $160,288 |
| XdemvyLotilaner | 58 | $109,221 |
| CequaCyclosporine | 99 | $100,659 |
| LumiganBimatoprost | 167 | $82,366 |
| MieboPerfluorohexyloctane/Pf | 64 | $53,745 |
| Cyclosporine | 66 | $48,299 |
| TyrvayaVarenicline Tartrate | 33 | $30,673 |
| VevyeCyclosporine | 23 | $17,776 |
| XiidraLifitegrast | 19 | $17,541 |
| VyzultaLatanoprostene Bunod | 19 | $11,529 |
| EysuvisLoteprednol Etabonate | 15 | $7,814 |
| RocklatanNetarsudil Mesylat/Latanoprost | 11 | $6,017 |
| FlarexFluorometholone Acetate | 31 | $3,783 |
| Brimonidine Tartrate | 44 | $3,111 |
| VuityPilocarpine Hcl | 14 | $1,157 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Vuity | $14,669 | $243,810329 claims |
| Tarsus Pharmaceuticals, Inc.Xdemvy | $260 | $109,22158 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $28,807 | $100,65999 claims |
| Bausch & Lomb Americas Inc.Miebo, Xiidra, Vyzulta | $954 | $82,814102 claims |
| Oyster Point Pharma, Inc.Tyrvaya | $1,319 | $30,67333 claims |
| Harrow Eye, LLCVevye | $618 | $17,77623 claims |
| Kala Pharmaceuticals, Inc.Eysuvis | $245 | $7,81415 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan | $146 | $6,01711 claims |
| Eyevance Pharmaceuticals LLCFlarex | $858 | $3,78331 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,122 optometrist providers in Tennessee.
Other optometrist in Dyersburg
- Christopher LievensMemphis$566K
- Whitney HauserMemphis$330K
- Torrey CarlsonKingsport$192K
- Frances BynumMartin$162K
- Melvin FriedmanMemphis$108K
- Kurt SteeleNewport$90K
- Jennifer DrakeColumbia$84K
- Travis JohnsonMurfreesboro$71K
- Desirae BrinkleyMemphis$51K
- Jeffrey SonsinoNashville$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.